This is one of those alternative treatments. Why would clearing out arteries have any benefit if the forces of the neuronal cascade of death are allowed to continue?
http://www.medpagetoday.com/Cardiology/Strokes/37247
A chelating agent targeting zinc that showed promise in early studies
failed to improve outcomes in patients with acute ischemic stroke, a
prematurely-terminated randomized trial showed.
At 90 days after
the stroke, the distribution of modified Rankin scores was similar in
the patients who received the agent -- DP-b99 -- and those who
received placebo (P=0.21), according to Kennedy Lees, MD, of the University of Glasgow in Scotland, and colleagues.
Rates of mortality and adverse events did not differ between the two groups, the researchers reported online in Stroke: Journal of the American Heart Association. The findings also were presented at the International Stroke Conference in Honolulu.
More:
No comments:
Post a Comment